Science and society: Advocacy groups as research organizations: the PXE International example
暂无分享,去创建一个
Sharon F. Terry | Jouni Uitto | Katherine A. Rauen | S. Terry | J. Uitto | K. Rauen | Patrick F. Terry | Lionel G. Bercovitch | L. Bercovitch
[1] Hilla Peretz,et al. Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .
[2] L. Tsui,et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.
[3] M. Peruffo,et al. Yellowish Papules on Flexural Areas of a Child , 2002, Pediatric dermatology.
[4] M. Zitter. Managing drugs for rare genetic diseases: trends and insights. , 2005, Managed care.
[5] S. Steinberg,et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. , 2003, Archives of internal medicine.
[6] Karen Marder,et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Sharon F Terry,et al. Learning genetics. , 2003, Health affairs.
[8] M. Lebwohl,et al. International Centennial Meeting on Pseudoxanthoma Elasticum: progress in PXE research. , 1998, The Journal of investigative dermatology.
[9] J. Kerner. Knowledge translation versus knowledge integration: A “funder's” perspective , 2006, The Journal of continuing education in the health professions.
[10] E. Marshall. Patient Advocate Named Co-Inventor On Patent for the PXE Disease Gene , 2004, Science.
[11] F. Collins,et al. A vision for the future of genomics research , 2003, Nature.
[12] Jeremy Sugarman,et al. Ethical issues in identifying and recruiting participants for familial genetic research , 2004, American journal of medical genetics. Part A.
[13] L. J. Hardies,et al. Growth hormone benefits children with 18q deletions , 2005, American journal of medical genetics. Part A.
[14] Empowering the Public to Be Informed Consumers of Genetic Technologies and Services , 2001, Public Health Genomics.
[15] Pablo Rodriguez-Viciana,et al. Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome , 2006, Science.
[16] S. Terry,et al. Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa , 2002, Human Genetics.
[17] M. Cho,et al. Protecting subjects' interests in genetics research. , 2002, American journal of human genetics.
[18] D. Shickle. The consent problem within DNA biobanks. , 2006, Studies in history and philosophy of biological and biomedical sciences.
[19] R. Dresser. Public advocacy and allocation of federal funds for biomedical research. , 1999, The Milbank quarterly.
[20] Stylianos E. Antonarakis,et al. Mendelian disorders deserve more attention , 2006, Nature Reviews Genetics.
[21] T. D. Wilson,et al. Editorial , 1997, Brain Research Bulletin.
[22] Stephen B. Johnson,et al. Central challenges facing the national clinical research enterprise. , 2003, JAMA.
[23] M. Lebwohl,et al. Mammographic findings in pseudoxanthoma elasticum. , 2003, Journal of the American Academy of Dermatology.
[24] Lionel Bercovitch,et al. Pseudoxanthoma elasticum 2004. , 2004, Journal of the American Academy of Dermatology.
[25] J. Schensul. Organizing Community Research Partnerships in the Struggle against AIDS , 1999, Health education & behavior : the official publication of the Society for Public Health Education.
[26] D. Socolar,et al. No Exit and the Organization of Voice in Biotechnology and Pharmaceuticals , 2003, Journal of health politics, policy and law.
[27] M. Davisson,et al. The bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Haines,et al. A genetic linkage map of the chromosome 4 short arm , 1993, Somatic cell and molecular genetics.
[29] S. Groft. Fostering research partnerships: a perspective from The Office of Rare Diseases (ORD). , 2005, Retina.
[30] Clayton M. Christensen,et al. Disruptive innovation: a new diagnosis for health care's "financial flu". , 2002, Healthcare financial management : journal of the Healthcare Financial Management Association.
[31] A. Young,et al. A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.
[32] S. Terry,et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum , 2000, Nature Genetics.
[33] Laura Scott,et al. Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome , 2003, Nature.
[34] J. Kaiser. Court Decides Tissue Samples Belong to University, Not Patients , 2006, Science.
[35] J. Weiss,et al. The role of genetic support groups. , 1994, Journal of Obstetric, Gynecologic and Neonatal Nursing.
[36] M Gwinn,et al. Informed consent for population-based research involving genetics. , 2001, JAMA.
[37] M. Kool,et al. Mutations in ABCC6 cause pseudoxanthoma elasticum , 2000, Nature Genetics.
[38] S. Terry,et al. Extracutaneous Ultrastructural Alterations in Pseudoxanthoma Elasticum , 2003, Ultrastructural pathology.
[39] S. Terry,et al. The placenta in pseudoxanthoma elasticum: clinical, structural and immunochemical study. , 2001, Placenta.
[40] S. Terry,et al. A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum. , 2001, American journal of human genetics.